Compare $ALLR vs $KTTA | Chartloom

Compare

$ALLR vs $KTTA

Allarity Therapeutics Inc · Pasithea Therapeutics Corp

ALLR

Allarity Therapeutics Inc

KTTA

Pasithea Therapeutics Corp

Compare $ALLR vs $KTTA

Comparing Allarity Therapeutics Inc and Pasithea Therapeutics Corp

ALLRAllarity Therapeutics Inc

KTTAPasithea Therapeutics Corp

ALLRAllarity Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-13.2%

52W performance

-41.8%

FCF yield

-87.5%

KTTAPasithea Therapeutics Corp

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

740.5%

YTD performance

-60.7%

52W performance

-43.0%

FCF yield

-113.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALLR

KTTA

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

KTTA

Pasithea Therapeutics Corp

Market Cap

ALLR$16M

KTTA$16M

Enterprise Value

ALLR$21M

KTTA$-30M

Price

ALLR$0.99

KTTA$0.47

P/E Ratio

ALLRN/A

KTTAN/A

P/S Ratio

ALLR45.65x

KTTA26.84x

EV/Sales

ALLR61.03x

KTTA0.00x

EV/EBITDA

ALLR0.00x

KTTA0.00x

P/B Ratio

ALLR4.68x

KTTA0.32x

P/FCF Ratio

ALLRN/A

KTTAN/A

EV/FCF

ALLR-1.53x

KTTA1.69x

PEG Ratio

ALLRN/A

KTTAN/A

Forward P/E (NTM)

ALLRN/A

KTTAN/A

Forward P/S (NTM)

ALLRN/A

KTTAN/A

Revenue (TTM)

ALLR$345K

KTTA$0

Revenue Growth (YoY)

ALLRN/A

KTTA740.5%

Forward Rev Growth

ALLR0.0%

KTTA0.0%

Gross Margin (TTM)

ALLR0.0%

KTTA100.5%

Operating Margin (TTM)

ALLR0.0%

KTTA0.0%

EBITDA Margin (TTM)

ALLR-771.9%

KTTA0.0%

Net Margin (TTM)

ALLR-3575.1%

KTTA0.0%

FCF Margin (TTM)

ALLR-3994.8%

KTTAN/A

Net Income (TTM)

ALLR$-12M

KTTA$-21M

FCF (TTM)

ALLR$-14M

KTTA$-18M

EPS (TTM)

ALLR-$0.78

KTTA-$0.66

ROE (TTM)

ALLR-15277.0%

KTTA-4949.0%

ROA (TTM)

ALLR-4650.0%

KTTA-4681.0%

ROIC (TTM)

ALLR-6256.0%

KTTA-4949.0%

Cash

ALLR$17M

KTTA$46M

Debt

ALLR$22M

KTTA$0

Net Cash/Debt

ALLR$-5M

KTTA$46M

Current Ratio (TTM)

ALLR1.11x

KTTA26.25x

Quick Ratio (TTM)

ALLR0.99x

KTTA24.91x

Debt/Equity (TTM)

ALLR6.30x

KTTA0.00x

Debt/Assets (TTM)

ALLR0.0%

KTTA0.0%

Interest Coverage (TTM)

ALLRN/A

KTTAN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

KTTA0.00x

Beta

ALLR0.60

KTTA0.39

52W Performance

ALLR-41.8%

KTTA-43.0%

YTD Performance

ALLR-13.2%

KTTA-60.7%

% from 52W High

ALLR-46.2%

KTTA-77.3%

% from 52W Low

ALLR28.6%

KTTA66.4%

Asset Turnover (TTM)

ALLR0.00x

KTTA0.01x

FCF Yield (TTM)

ALLR-87.5%

KTTA-113.8%

Earnings Yield (TTM)

ALLR-78.3%

KTTA-136.3%

Dividend Yield (TTM)

ALLRN/A

KTTAN/A

Rule of 40

ALLR-3,994.8

KTTA740.5

EV/GP/RG

ALLRN/A

KTTAN/A

Ticker research

View ALLR research View KTTA research

Metric	ALLR Allarity Therapeutics Inc	KTTA Pasithea Therapeutics Corp
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$21M	$-30M
Price	$0.99	$0.47
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	26.84x
EV/Sales	61.03x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.68x	0.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	1.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$345K	$0
Revenue Growth (YoY)	N/A	740.5%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	100.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	0.0%
Net Margin (TTM)	-3575.1%	0.0%
FCF Margin (TTM)	-3994.8%	N/A
Net Income (TTM)	$-12M	$-21M
FCF (TTM)	$-14M	$-18M
EPS (TTM)	-$0.78	-$0.66
ROE (TTM)	-15277.0%	-4949.0%
ROA (TTM)	-4650.0%	-4681.0%
ROIC (TTM)	-6256.0%	-4949.0%
Financial Health
Cash	$17M	$46M
Debt	$22M	$0
Net Cash/Debt	$-5M	$46M
Current Ratio (TTM)	1.11x	26.25x
Quick Ratio (TTM)	0.99x	24.91x
Debt/Equity (TTM)	6.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	0.39
52W Performance	-41.8%	-43.0%
YTD Performance	-13.2%	-60.7%
% from 52W High	-46.2%	-77.3%
% from 52W Low	28.6%	66.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-87.5%	-113.8%
Earnings Yield (TTM)	-78.3%	-136.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	740.5
EV/GP/RG	N/A	N/A
Ticker research	View ALLR research	View KTTA research

Valuation

P/S Ratio

KTTA

26.84x

ALLR

45.65x

EV/FCF

ALLR

-1.53x

KTTA

1.69x

Growth & revenue

Revenue Growth TTM

KTTA

740.5%

Forward Revenue Growth

ALLR

0.0%

KTTA

0.0%

Profitability & performance

Gross Margin

KTTA

100.5%

ALLR

0.0%

ROE

KTTA

-4949.0%

ALLR

-15277.0%

FCF Yield %

ALLR

-87.5%

KTTA

-113.8%

52-Week Performance

ALLR

-41.8%

KTTA

-43.0%

Detailed metrics comparison

ALLR

Allarity Therapeutics Inc

KTTA

Pasithea Therapeutics Corp

Market Cap

ALLR$16M

KTTA$16M

Enterprise Value

ALLR$21M

KTTA$-30M

Price

ALLR$0.99

KTTA$0.47

P/E Ratio

ALLRN/A

KTTAN/A

P/S Ratio

ALLR45.65x

KTTA26.84x

EV/Sales

ALLR61.03x

KTTA0.00x

EV/EBITDA

ALLR0.00x

KTTA0.00x

P/B Ratio

ALLR4.68x

KTTA0.32x

P/FCF Ratio

ALLRN/A

KTTAN/A

EV/FCF

ALLR-1.53x

KTTA1.69x

PEG Ratio

ALLRN/A

KTTAN/A

Forward P/E (NTM)

ALLRN/A

KTTAN/A

Forward P/S (NTM)

ALLRN/A

KTTAN/A

Revenue (TTM)

ALLR$345K

KTTA$0

Revenue Growth (YoY)

ALLRN/A

KTTA740.5%

Forward Rev Growth

ALLR0.0%

KTTA0.0%

Gross Margin (TTM)

ALLR0.0%

KTTA100.5%

Operating Margin (TTM)

ALLR0.0%

KTTA0.0%

EBITDA Margin (TTM)

ALLR-771.9%

KTTA0.0%

Net Margin (TTM)

ALLR-3575.1%

KTTA0.0%

FCF Margin (TTM)

ALLR-3994.8%

KTTAN/A

Net Income (TTM)

ALLR$-12M

KTTA$-21M

FCF (TTM)

ALLR$-14M

KTTA$-18M

EPS (TTM)

ALLR-$0.78

KTTA-$0.66

ROE (TTM)

ALLR-15277.0%

KTTA-4949.0%

ROA (TTM)

ALLR-4650.0%

KTTA-4681.0%

ROIC (TTM)

ALLR-6256.0%

KTTA-4949.0%

Cash

ALLR$17M

KTTA$46M

Debt

ALLR$22M

KTTA$0

Net Cash/Debt

ALLR$-5M

KTTA$46M

Current Ratio (TTM)

ALLR1.11x

KTTA26.25x

Quick Ratio (TTM)

ALLR0.99x

KTTA24.91x

Debt/Equity (TTM)

ALLR6.30x

KTTA0.00x

Debt/Assets (TTM)

ALLR0.0%

KTTA0.0%

Interest Coverage (TTM)

ALLRN/A

KTTAN/A

Net Debt/EBITDA (TTM)

ALLR0.00x

KTTA0.00x

Beta

ALLR0.60

KTTA0.39

52W Performance

ALLR-41.8%

KTTA-43.0%

YTD Performance

ALLR-13.2%

KTTA-60.7%

% from 52W High

ALLR-46.2%

KTTA-77.3%

% from 52W Low

ALLR28.6%

KTTA66.4%

Asset Turnover (TTM)

ALLR0.00x

KTTA0.01x

FCF Yield (TTM)

ALLR-87.5%

KTTA-113.8%

Earnings Yield (TTM)

ALLR-78.3%

KTTA-136.3%

Dividend Yield (TTM)

ALLRN/A

KTTAN/A

Rule of 40

ALLR-3,994.8

KTTA740.5

EV/GP/RG

ALLRN/A

KTTAN/A

Ticker research

View ALLR research View KTTA research

Metric	ALLR Allarity Therapeutics Inc	KTTA Pasithea Therapeutics Corp
Market & Valuation
Market Cap	$16M	$16M
Enterprise Value	$21M	$-30M
Price	$0.99	$0.47
P/E Ratio	N/A	N/A
P/S Ratio	45.65x	26.84x
EV/Sales	61.03x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.68x	0.32x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.53x	1.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$345K	$0
Revenue Growth (YoY)	N/A	740.5%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	100.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-771.9%	0.0%
Net Margin (TTM)	-3575.1%	0.0%
FCF Margin (TTM)	-3994.8%	N/A
Net Income (TTM)	$-12M	$-21M
FCF (TTM)	$-14M	$-18M
EPS (TTM)	-$0.78	-$0.66
ROE (TTM)	-15277.0%	-4949.0%
ROA (TTM)	-4650.0%	-4681.0%
ROIC (TTM)	-6256.0%	-4949.0%
Financial Health
Cash	$17M	$46M
Debt	$22M	$0
Net Cash/Debt	$-5M	$46M
Current Ratio (TTM)	1.11x	26.25x
Quick Ratio (TTM)	0.99x	24.91x
Debt/Equity (TTM)	6.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	0.39
52W Performance	-41.8%	-43.0%
YTD Performance	-13.2%	-60.7%
% from 52W High	-46.2%	-77.3%
% from 52W Low	28.6%	66.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-87.5%	-113.8%
Earnings Yield (TTM)	-78.3%	-136.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,994.8	740.5
EV/GP/RG	N/A	N/A
Ticker research	View ALLR research	View KTTA research